Estimation of Sojourn Time in Chronic Disease Screening Without Data on Interval Cases
DOI10.1111/J.0006-341X.2000.00167.XzbMATH Open1060.62588OpenAlexW2076613374WikidataQ30592963 ScholiaQ30592963MaRDI QIDQ4668396FDOQ4668396
Authors: Tony Hsiu-Hsi Chen, H. S. Kuo, Ming-Fang Yen, Maosheng Lai, Laszlo Tabar, Stephen W. Duffy 
Publication date: 19 April 2005
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1111/j.0006-341x.2000.00167.x
Recommendations
- Simplified Models of Screening for Chronic Disease: Estimation Procedures from Mass Screening Programmes
- How well can screening sensitivity and sojourn time be estimated
- Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution
- Parametric estimation procedures for screening programmes: stable and nonstable disease models for multimodality case finding
- Estimating Lead Time and Sensitivity in a Screening Program without Estimating the Incidence in the Screened Group
Markov processes: estimation; hidden Markov models (62M05) Applications of statistics to biology and medical sciences; meta analysis (62P10)
Cites Work
Cited In (18)
- Bayesian Modeling of Multiple Lesion Onset and Growth from Interval-Censored Data
- MLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic Screening
- A stochastic model for calibrating the survival benefit of screen-detected cancers
- Likelihood function for estimating parameters in multistate disease process with Laplace-transformation-based transition probabilities
- Time-varying Markov regression random-effect model with Bayesian estimation procedures: Application to dynamics of functional recovery in patients with stroke
- How well can screening sensitivity and sojourn time be estimated
- Modeling the overdetection of screen-identified cancers in population-based cancer screening with the Coxian phase-type Markov process
- A multistate survival model of the natural history of cancer using data from screened and unscreened population
- Screening for a chronic disease: a multiple stage duration model with partial observability
- Tailored optimal posttreatment surveillance for cancer recurrence
- A Bayesian Random‐Effects Markov Model for Tumor Progression in Women with a Family History of Breast Cancer
- Modelling multi-stage processes through multivariate distributions
- Nonparametric Estimation of Asymptomatic Duration from a Randomized Prospective Cancer Screening Trial
- Stochastic models for multiple pathways of temporal natural history on co-morbidity of chronic disease
- Modeling Tumor Growth with Random Onset
- A stochastic model for survival of early prostate cancer with adjustments for leadtime, length bias, and over-detection
- Bayesian modeling of incidence and progression of disease from cross-sectional data
- An Early‐ and Late‐Stage Convolution Model for Disease Natural History
This page was built for publication: Estimation of Sojourn Time in Chronic Disease Screening Without Data on Interval Cases
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4668396)
